Atea Pharmaceuticals Inc (AVIR) — Capital Reinvestment Ratio
Latest as of September 2021:
0.00x
Atea Pharmaceuticals Inc (AVIR) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow ($22.60 Million) in capital expenditures ($4.00K). See cash generation quality of Atea Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$22.60 Million
USD
Capital Expenditures
$4.00K
USD
Data as of
Sep 2021
Most recent filing
Atea Pharmaceuticals Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Atea Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Atea Pharmaceuticals Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Atea Pharmaceuticals Inc from 2020 to 2020. For live market cap and broader valuation context, see market value of Atea Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $296.73 Million | $26.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow